EDESA BIOTECH, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

Published: 2022-05-20 06:49:06 ET EDSA

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 18, 2022, Edesa Biotech, Inc. (the "Company") held its 2022 annual general meeting of shareholders (the "Annual Meeting"). At the Annual Meeting, 6,975,601 common shares, or approximately 50.1% of the outstanding common shares entitled to vote, were represented by proxy or in person. The matters voted on by shareholders at the Annual Meeting and the results of such voting are set forth below.

Proposal No. 1 - Election of the Company's Directors

Based upon the following votes, the shareholders elected Jennifer Chao, Lorin Johnson, Sean MacDonald, Pardeep Nijhawan, Frank Oakes, Paul Pay and Carlo Sistilli to serve as members of the Company's board of directors until the annual general meeting of shareholders to be held in 2023 or until their successors are duly elected and qualified.

Proposal No. 2 - Advisory Vote on Executive Compensation

The shareholders approved, on an advisory basis, the executive compensation of the named executive officers as disclosed in the Proxy Statement, by the following vote:

Proposal No. 3 - Advisory Vote on the Frequency of an Advisory Vote on Executive Compensation

The shareholders voted, on an advisory basis, for "every year" on the frequency of future proposals on executive compensation as set forth below.

Upon consideration of the results, the Company has determined to hold future non-binding, advisory votes on executive compensation annually until the next such advisory vote on frequency or at such time as the Company's Board of Directors otherwise determines that a different frequency for such advisory vote on executive compensation is in the best interests of the shareholders of the Company.

Proposal No. 4 - Appointment of MNP LLP as the Company's Auditors and Independent Registered Public Accounting Firm for the Ensuing Year

Based upon the following votes, the shareholders approved the appointment of MNP LLP as the Company's independent registered public accounting firm until the close of the 2023 annual meeting of shareholders or until a successor is appointed.